Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Inks $17M Financing Deal

NEW YORK (GenomeWeb News) – OpGen has completed an agreement with new and existing investors to provide the firm with up to $17 million in a Series C financing.

The Gaithersburg, Md.-based firm said that the proceeds will be used to accelerate commercialization of its Argus Whole Genome Mapping System and Genome-Builder tool suite for large genome sequencing assembly and data analysis. OpGen also has plans to introduce a new application for whole human chromosome mapping that can be combined with next-generation sequencing techniques to improve the accuracy of human genome sequencing.

According to a filing with the US Securities and Exchange Commission last month, OpGen had raised $3.5 million, which a spokesman confirmed was part of the Series C round.

New investors in the round included Harris & Harris Group and Cross Creek Capital, an affiliate of Wasatch Advisors, as well as previous investors Highland Capital Partners, Versant Ventures, jVen Capital, and CHL Medical Partners.

In a separate statement, Harris & Harris disclosed that its investment in the round was $815,000. It also noted that its Managing Director, Misti Ushio, will join OpGen's board of directors.

"For the past several years, Harris & Harris Group has been looking for the next transformative technology that goes beyond high-throughput sequencing," Ushio said in a statement. "We are excited to have the opportunity to invest in OpGen, which has launched its Whole Genome Mapping system enabling rapid analysis of structural variation."

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.